Delivery Order SPE2DE24D0013-SPE2D625F3XHX
Award Date 9/19/25
Potential Completion Date 9/26/25
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $3,638 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on May 30, 2025, with an ultimate completion date of June 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and is for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus detection. The work will be performed at Cepheid's facility in...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $12,040 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 21, 2025, with completion expected by August 28, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, does not utilize a set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award supports the federal government's diagnostic testing capabilities through Cepheid's molecular diagnostic solutions,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17,000 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 19, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, designated as XPCOV2/FLU/RSV-10, has an ultimate completion date of August 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for...
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,580 to Cepheid Inc. (UEI: W6HQTMWB9Q28) for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The firm fixed-price delivery order, issued on August 7, 2025, is scheduled for completion by August 14, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation, indicating it was...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a molecular diagnostics manufacturer based in Sunnyvale, California. This award, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents a standard delivery order contract type. The contract enables procurement of Cepheid's diagnostic solutions, which the company supplies across...
- The Defense Department's Medical Supply Chain has awarded a $24,088.95 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, represents procurement under Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. The delivery order designation...